These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 29698921)

  • 1. Synthesis, characterization of novel N-(4-cyano-1,3-oxazol-5-yl)sulfonamide derivatives and in vitro screening their activity against NCI-60 cancer cell lines.
    Severin O; Pilyo S; Kachaeva M; Zhirnov V; Hodyna D; Bahrieieva O; Brovarets V
    ChemMedChem; 2024 Mar; 19(5):e202300527. PubMed ID: 38241069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, Docking, and Machine Learning Studies of Some Novel Quinolinesulfonamides-Triazole Hybrids with Anticancer Activity.
    Marciniec K; Nowakowska J; Chrobak E; Bębenek E; Latocha M
    Molecules; 2024 Jul; 29(13):. PubMed ID: 38999109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Boosting Sinh Cosh Optimizer and arithmetic optimization algorithm for improved prediction of biological activities for indoloquinoline derivatives.
    Ibrahim RA; Aly Saad Aly M; Moemen YS; El Tantawy El Sayed I; Abd Elaziz M; Khalil HA
    Chemosphere; 2024 Jul; 359():142362. PubMed ID: 38768786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity models of oral clearance, cytotoxicity, and LD50: a screen for promising anticancer compounds.
    Boik JC; Newman RA
    BMC Pharmacol; 2008 Jun; 8():12. PubMed ID: 18554402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of 2-quinolyl-1,3-tropolone derivatives as new anti-cancer agents.
    Gusakov EA; Topchu IA; Mazitova AM; Dorogan IV; Bulatov ER; Serebriiskii IG; Abramova ZI; Tupaeva IO; Demidov OP; Toan DN; Lam TD; Bang DN; Boumber YA; Sayapin YA; Minkin VI
    RSC Adv; 2021; 11(8):4555-4571. PubMed ID: 33996031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QSAR modeling for cytotoxicity of sulfur-containing Shikonin oxime derivatives targeting HCT-15, MGC-803, BEL-7402, and MCF-7 cell lines.
    Diane A; Ben Tahar S; El Mrabet A; Rabie R; Saffaj T; Ihssane B
    Toxicol In Vitro; 2024 Oct; 100():105892. PubMed ID: 38996828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and Antimicrobial Activity of New Heteroaryl(aryl) Thiazole Derivatives Molecular Docking Studies.
    Kartsev V; Geronikaki A; Zubenko A; Petrou A; Ivanov M; Glamočlija J; Sokovic M; Divaeva L; Morkovnik A; Klimenko A
    Antibiotics (Basel); 2022 Sep; 11(10):. PubMed ID: 36289995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, Synthesis, and Cytotoxic Activity of Novel Natural Arylsulfonamide-Inspired Molecules.
    Huang W; Shi L; Liu M; Zhang Z; Liu F; Long T; Wen S; Huang D; Wang K; Zhou R; Fang W; Hu H; Ke S
    Molecules; 2022 Feb; 27(5):. PubMed ID: 35268580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Sulfanilamide Derivatives Incorporating Heterocyclic Carboxamide Moieties as Carbonic Anhydrase Inhibitors.
    Angeli A; Kartsev V; Petrou A; Pinteala M; Vydzhak RM; Panchishin SY; Brovarets V; De Luca V; Capasso C; Geronikaki A; Supuran CT
    Pharmaceuticals (Basel); 2021 Aug; 14(8):. PubMed ID: 34451924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromene-Containing Aromatic Sulfonamides with Carbonic Anhydrase Inhibitory Properties.
    Angeli A; Kartsev V; Petrou A; Pinteala M; Brovarets V; Slyvchuk S; Pilyo S; Geronikaki A; Supuran CT
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34064890
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Semenyuta IV; Kobzar OL; Hodyna DM; Brovarets VS; Metelytsia LO
    Heliyon; 2019 Apr; 5(4):e01462. PubMed ID: 31011642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and evaluation of novel sulfonamides as potential anticancer agents.
    Kachaeva MV; Hodyna DM; Semenyuta IV; Pilyo SG; Prokopenko VM; Kovalishyn VV; Metelytsia LO; Brovarets VS
    Comput Biol Chem; 2018 Jun; 74():294-303. PubMed ID: 29698921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and antiproliferative activity of the new conjugates of E7010 and resveratrol as tubulin polymerization inhibitors.
    Kamal A; Ashraf M; Basha ST; Ali Hussaini SM; Singh S; Vishnuvardhan MV; Kiran B; Sridhar B
    Org Biomol Chem; 2016 Jan; 14(4):1382-94. PubMed ID: 26676480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of anticancer activity of some novel 6-aryl-2-(p-sulfamylphenyl)-pyridazin-3(2H)-ones.
    Rathish IG; Javed K; Ahmad S; Bano S; Alam MS; Akhter M; Pillai KK; Ovais S; Samim M
    Eur J Med Chem; 2012 Mar; 49():304-9. PubMed ID: 22305543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, Antiproliferative Activity and Molecular Docking Studies of Novel Doubly Modified Colchicine Amides and Sulfonamides as Anticancer Agents.
    Krzywik J; Mozga W; Aminpour M; Janczak J; Maj E; Wietrzyk J; Tuszyński JA; Huczyński A
    Molecules; 2020 Apr; 25(8):. PubMed ID: 32295119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Development of Sulfonyl or Sulfonamide Hybrids as Potential Anticancer Agents: A Key Review.
    Rakesh KP; Wang SM; Leng J; Ravindar L; Asiri AM; Marwani HM; Qin HL
    Anticancer Agents Med Chem; 2018; 18(4):488-505. PubMed ID: 29110622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticancer drug design using scaffolds of β-lactams, sulfonamides, quinoline, quinoxaline and natural products. Drugs advances in clinical trials.
    Balderas-Renteria I; Gonzalez-Barranco P; Garcia A; Banik BK; Rivera G
    Curr Med Chem; 2012; 19(26):4377-98. PubMed ID: 22709002
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.